INVESTOR NEWS
December 2012
Symrise and Probi sign joint research and development agreement
• Bundling of expertise in developing new product solutions in the areas of food and beverages, cosmetics, dietary supplements and pharmaceuticals • Initial focus on oral care...» More
November 2012
Sales and Earnings up 9 % in the First Nine Months
• Emerging Markets account for 48 % of sales for the first time
• EBITDA margin of 20 % despite persistently high raw material prices and start-up
costs for...» More
August 2012
Symrise AG Increases Sales and EBITDA by 7 % in the First Half of the Year
• EBITDA margin of 20 % despite ongoing high raw material prices
• Share of sales from Emerging Markets up to 47 %
• Earnings per share rise to € 0.71
• Outlook for the full...» More
May 2012
Symrise Starts Fiscal Year with Robust Sales Growth
• Sales rise 4% to €433 million
• EBITDA margin of 20.1% despite higher raw material costs
• Sales with global customers up 10%
• Symrise raises sales forecast for Fiscal...» More
March 2012
Symrise in 2011 again highly profitable with an EBITDA margin of 20 %
• Target EBITDA margin reached despite steep rise in cost of raw materials
• Sales up by 2 % to € 1.584 billion
• Sales increase by 7 % in business with global...» More
